Methane bioconversion: Farnesene
| Organization | Intrexon |
|---|---|
| Market status | Early Stage Concept |
| Industry | Energy + Industrial |
| Value chain stage | Input |
| Business models | B2B |
| Product categories | Fuel and Energy + Chemical |
| Biotech components | Bacteria + Gene Editing |
| Organization type(s) | Public Company |
| Funding types | Shareholder Investment |
| Trading symbol | XON |
| Trading exchange | NASDAQ |